Increasing Documentation and Disclosure of Sickle Cell Trait Carrier Status: An Implementation Science Approach

增加镰状细胞性状携带者状态的记录和披露:一种实施科学方法

基本信息

项目摘要

PROJECT SUMMARY The hemoglobinopathy newborn screen (NBS) performed on all neonates in the U.S. allows for early life-sav- ing medical care for infants with sickle cell disease (SCD). Because of its detection method, the NBS inci- dentally reveals hemoglobinopathy carrier states including sickle cell trait (SCT). Such findings present a unique ethical challenge: Whether to disclose the newborn’s carrier status and, by default, the carrier status of one parent. In an effort to uphold the rights of the newborn and parent to their medical data (i.e., NBS result, SCT status) and preserve autonomy in medical decision making, pediatric and genetic society guidelines rec- ommend disclosure and documentation of NBS SCT carrier results during infancy. Despite this ethical impera- tive, a large guideline-to-practice gap exists: SCT carrier status is grossly under-documented in the pediatric electronic health record (EHR) and few adults report knowing their SCT status despite universal screening. Failure to disclose SCT carrier status obstructs an individual’s ability to make informed reproductive decisions. Additionally, lack of documentation of SCT carrier status hampers physicians’ and researchers’ abilities to identify the growing list of medical complications attributed to SCT. We propose to use implementation science methods to close this practice gap for the nearly 3 million carriers of SCT in the US, most of whom are Black or Hispanic. Using mixed method qualitative and quantitative methods we will identify the barriers, facilitators, and implementation strategies necessary to increase: 1) the documentation of NBS and SCT carrier status within the EHR; 2) disclosure of results to caregivers during infancy; and, 3) discussions about reproduction implica- tions with adolescent SCT carriers. We will develop and pilot test a SCT Documentation and Disclosure Toolkit for use by primary care physicians during infancy and an SCT Discussion Toolkit for use with adolescents. Ac- curate documentation and disclosure of NBS results and SCT carrier status is critical to the responsible and ethical care of patients with SCT; will improve health outcomes; and will reduce inequities in care.
项目摘要 对美国所有新生儿进行的血红蛋白病新生儿筛查(NBS)允许早期挽救生命, 为患有镰状细胞病(SCD)的婴儿提供医疗护理。由于其检测方法,NBS包括- 牙齿显示血红蛋白病携带者状态,包括镰状细胞性状(SCT)。这些发现提出了一个 独特的伦理挑战:是否披露新生儿的携带者状态,以及默认情况下, 一个家长为了维护新生儿和父母对其医疗数据的权利(即,国家统计局的结果, SCT状态)和保留医疗决策的自主权,儿科和遗传学会指南建议- 建议在婴儿期披露和记录NBS SCT携带者结果。尽管这是一种道德规范, 然而,指南与实践之间存在很大的差距:SCT携带者状态在儿科中的记录严重不足。 电子健康记录(EHR)和少数成年人报告知道他们的SCT状态,尽管普遍筛查。 不披露SCT携带者身份会妨碍个人做出知情生育决定的能力。 此外,缺乏SCT携带者状态的文件阻碍了医生和研究人员的能力, 确定SCT引起的日益增多的医疗并发症。我们建议使用实施科学 在美国,近300万SCT携带者,其中大多数是黑人或黑人, 西班牙裔使用定性和定量的混合方法,我们将确定障碍,促进因素, 必要的实施战略,以增加:1)NBS和SCT携带者状态的文件, EHR; 2)在婴儿期向看护者披露结果;以及,3)关于生殖含义的讨论- 青少年SCT携带者。我们将开发和试点测试SCT文档和披露工具包 供初级保健医生在婴儿期使用,以及供青少年使用的SCT讨论工具包。交流 对NBS结果和SCT载体状态进行精心记录和披露对负责人和 SCT患者的伦理护理;将改善健康结果;并将减少护理中的不公平。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Corinna Lee Schultz其他文献

Corinna Lee Schultz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Corinna Lee Schultz', 18)}}的其他基金

Increasing Documentation and Disclosure of Sickle Cell Trait Carrier Status: An Implementation Science Approach
增加镰状细胞性状携带者状态的记录和披露:一种实施科学方法
  • 批准号:
    10271043
  • 财政年份:
    2014
  • 资助金额:
    $ 29.84万
  • 项目类别:
Increasing Documentation and Disclosure of Sickle Cell Trait Carrier Status: An Implementation Science Approach
增加镰状细胞性状携带者状态的记录和披露:一种实施科学方法
  • 批准号:
    10664919
  • 财政年份:
    2014
  • 资助金额:
    $ 29.84万
  • 项目类别:

相似海外基金

Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa
COVID-19 大流行期间健康社会决定因素的变化对青少年和年轻人心理健康的影响:南非 Asenze 队列的纵向研究
  • 批准号:
    10755168
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
  • 批准号:
    480840
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Miscellaneous Programs
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
  • 批准号:
    10678157
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
  • 批准号:
    10744412
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
  • 批准号:
    23K07305
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
  • 批准号:
    23H02874
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effects of adolescent social isolation on adult decision making and corticostriatal circuitry
青少年社会隔离对成人决策和皮质纹状体回路的影响
  • 批准号:
    10756652
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
Adolescent trauma produces enduring disruptions in sleep architecture that lead to increased risk for adult mental illness
青少年创伤会对睡眠结构产生持久的破坏,从而导致成人精神疾病的风险增加
  • 批准号:
    10730872
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors
使用量身定制的移动健康策略促进青少年和年轻癌症幸存者的体重管理
  • 批准号:
    10650648
  • 财政年份:
    2023
  • 资助金额:
    $ 29.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了